The effect of aspirin on the antiproteinuric properties of enalapril in microalbuminuric type 2 diabetic patients: a randomized, double-blind, placebo-controlled study

Diabetes Care. 2007 Jul;30(7):e66. doi: 10.2337/dc07-0187.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Aspirin / pharmacology*
  • Cardiovascular Agents / pharmacology*
  • Cross-Over Studies
  • Diabetes Mellitus, Type 2 / complications
  • Double-Blind Method
  • Drug Interactions
  • Enalapril / pharmacology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Proteinuria / drug therapy*
  • Proteinuria / etiology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiovascular Agents
  • Enalapril
  • Aspirin